Vol 2007, No 80 (2007)

Table of Contents

Cartoons

Big Pharma jpg
Business Review Editor

Deal Trackers

Junovan (mifamurtide) Abstract pdf
Business Review Editor

Research & Development

Cytokinetics and Amgen Enter into Collaboration for Heart Failure Abstract pdf
Business Review Editor
GlaxoSmithKline Further Improves its Biologics Capabilities Abstract pdf
Business Review Editor

Features

Seattle Genetics Boosts Cash Pile with January Deals Abstract pdf
Business Review Editor
When Giants Meet: Bristol-Myers Squibb and AstraZeneca Form Alliance for Diabetes Drug Abstract pdf
Business Review Editor
Nanotechnology for Drug Delivery: A Validated Technology? Abstract pdf
Business Review Editor
Therapy Focus: Parkinson#8217;s Disease Abstract pdf
Business Review Editor

Licensing

Boehringer and Ablynx Sign US$265 M Deal for Use of Nanobodies® in Alzheimer’s Disease Abstract pdf
Business Review Editor
Bayer Schering Pharma Builds on Core Schering Technology in Neurodegenerative Diseases Abstract pdf
Business Review Editor

General

Validation and Value: The Risk of RNAi Therapeutics Abstract
Business Review Editor
Elbion NV Abstract
Business Review Editor

Mergers & Acquisitions

Novartis to Divest Medical Nutrition Business Unit to Nestlé Abstract pdf
Business Review Editor

Business Commentaries

Funding Research Abstract html
Fintan Walton


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.